Skip to content

Horizon Therapeutics Public Ltd Co

Delisted

CIK 1492426fmd_0AD0X67JWX1EPWGPFQER79S50DManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Jun 30, 2023, 54 periods

Latest annual · FY2022

Millions
Total revenues
3,629
Gross profit
2,709
Operating income
617
Net income
521
Free cash flow
1,194

Latest quarter · Q2 FY2023

Millions
Total revenues
945
Gross profit
725
Operating income
143
Net income
127
Free cash flow
143
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2019 to FY2022
+40.8%
Revenue, 5 yearsFY2017 to FY2022
+28.0%
Net income, 5 yearsFY2017 to FY2022
n/m

Horizon Therapeutics Public Ltd Co financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2022FY2021ChangeSource
Revenue$3.6 billion$3.2 billion+12.5%10-K 2023-03-01 · proof
Gross profit$2.7 billion$2.4 billion+11.4%10-K 2023-03-01 · proof
Operating income$617.4 million$543.1 million+13.7%10-K 2023-03-01 · proof
Net income$521.5 million$534.5 million-2.4%10-K 2023-03-01 · proof
Cash from operating activities$1.3 billion$1 billion+21.5%10-K 2023-03-01 · proof
Free cash flow$1.2 billion$958.7 million+24.5%10-K 2023-03-01 · proof
Total assets$9.1 billion$8.7 billion+5%10-K 2023-03-01 · proof
Total liabilities$4 billion$4 billion+0.9%10-K 2023-03-01 · proof
Cash and cash equivalents$2.4 billion$1.6 billion+48.9%10-K 2023-03-01 · proof
Total debt$2.6 billion$2.6 billion-0.3%10-K 2023-03-01 · proof
What was Horizon Therapeutics Public Ltd Co's revenue in fiscal 2022?
Horizon Therapeutics Public Ltd Co reported revenue of $3.6 billion for fiscal 2022 (the year ended Dec 31, 2022), against $3.2 billion the year before (+12.5%). Source: the 10-K filed with the SEC on Mar 1, 2023. SEC
What was Horizon Therapeutics Public Ltd Co's gross profit in fiscal 2022?
Horizon Therapeutics Public Ltd Co reported gross profit of $2.7 billion for fiscal 2022 (the year ended Dec 31, 2022), against $2.4 billion the year before (+11.4%). Source: the 10-K filed with the SEC on Mar 1, 2023. SEC
What was Horizon Therapeutics Public Ltd Co's operating income in fiscal 2022?
Horizon Therapeutics Public Ltd Co reported operating income of $617.4 million for fiscal 2022 (the year ended Dec 31, 2022), against $543.1 million the year before (+13.7%). Source: the 10-K filed with the SEC on Mar 1, 2023. SEC
What was Horizon Therapeutics Public Ltd Co's net income in fiscal 2022?
Horizon Therapeutics Public Ltd Co reported net income of $521.5 million for fiscal 2022 (the year ended Dec 31, 2022), against $534.5 million the year before (-2.4%). Source: the 10-K filed with the SEC on Mar 1, 2023. SEC
What was Horizon Therapeutics Public Ltd Co's cash from operating activities in fiscal 2022?
Horizon Therapeutics Public Ltd Co reported cash from operating activities of $1.3 billion for fiscal 2022 (the year ended Dec 31, 2022), against $1 billion the year before (+21.5%). Source: the 10-K filed with the SEC on Mar 1, 2023. SEC
What was Horizon Therapeutics Public Ltd Co's free cash flow in fiscal 2022?
Horizon Therapeutics Public Ltd Co reported free cash flow of $1.2 billion for fiscal 2022 (the year ended Dec 31, 2022), against $958.7 million the year before (+24.5%). Source: the 10-K filed with the SEC on Mar 1, 2023. SEC
What are Horizon Therapeutics Public Ltd Co's total assets?
As of Dec 31, 2022, Horizon Therapeutics Public Ltd Co reported total assets of $9.1 billion, against $8.7 billion a year earlier (+5%). Source: the 10-K filed with the SEC on Mar 1, 2023. SEC
What are Horizon Therapeutics Public Ltd Co's total liabilities?
As of Dec 31, 2022, Horizon Therapeutics Public Ltd Co reported total liabilities of $4 billion, against $4 billion a year earlier (+0.9%). Source: the 10-K filed with the SEC on Mar 1, 2023. SEC
What are Horizon Therapeutics Public Ltd Co's cash and cash equivalents?
As of Dec 31, 2022, Horizon Therapeutics Public Ltd Co reported cash and cash equivalents of $2.4 billion, against $1.6 billion a year earlier (+48.9%). Source: the 10-K filed with the SEC on Mar 1, 2023. SEC
What is Horizon Therapeutics Public Ltd Co's total debt?
As of Dec 31, 2022, Horizon Therapeutics Public Ltd Co reported total debt of $2.6 billion, against $2.6 billion a year earlier (-0.3%). Source: the 10-K filed with the SEC on Mar 1, 2023. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1492426&period_type=annual&limit=5"

Information only, not investment advice.